Select to view the solutions available in your location.
Track orders, get results, manage personal information, and more.
Order tests, track orders, get results, and more.
Learn more about our innovative products and services that help detect cancer earlier and power smarter treatment decisions.
Find out how our scientific rigor, quality standards, and development of future tests make us a leader in cancer testing and treatment guidance.
Insights from the Alpha-CORRECT clinical validation study
Learn all about Exact Sciences, including our purpose, the people who drive it, our history, and the impact we’ve made.
Several Exact Sciences initiatives address disparities in cancer outcomes among U.S. Latinos.
Explore stories, news, and events that highlight our innovation, technology, and people fighting cancer on all fronts.
It’s Super Bowl Sunday in Arizona this weekend, but the healthcare industry’s Super Bowl played out earlier this month at the J.P. Morgan Healthcare Conference in San Francisco.
In a field crowded with established players with big news of their own, including Roche's buzz-worthy acquisition of a major stake in Foundation Medicine, Exact’s ability to deliver on our promises during the past year helped us stand out from the pack.
After speaking at the conference in past years, this year’s presentation before a standing-room-only crowd was especially fulfilling because of the significant milestones the Exact team achieved in 2014.
This included the publication of the pivotal Deep-C study results in the New England Journal of Medicine, the FDA’s approval of Cologuard and a final CMS coverage and pricing determination. Now, less than six months after approval we are seeing rapid clinician adoption and a direct impact on patients.